Laboratory Scientists & Researchers

Five major commercial publishers -- Elsevier, Springer Nature, Wiley, Taylor & Francis, and SAGE -- dominate scientific publishing, controlling 56% of articles published and capturing 75% of European spending on scientific journals. Elsevier's parent company Relx reported £3.2 billion in adjusted operating profit for 2024 with a margin of 38.4% -- exceeding Google's 34.3%. Article processing charges for open access publications nearly tripled between 2019 and 2023, with APC spending rising from $910.3 million to $2.5 billion. Top-tier journals like Nature charge upward of $10,000 per article, while Elsevier's APCs range from $200 to $11,400, creating a system where publicly funded researchers must pay to publish their own taxpayer-funded work.

NIH awards dropped 29% and NSF awards fell 50% in 2025 compared to recent years. Grant success rates for established investigators plunged from about 27% to 20%, while at-risk investigators saw rates fall from 24% to 17%. At the National Cancer Institute, success rates collapsed from one in 10 to one in 25 applicants. Researchers now spend an average of 40% of their time on grant-related activities rather than actual research, with 60% of principal investigators submitting more grants to compensate for lower success rates. One researcher estimated losing $1.1 million of his $3.3 million in NIH funding, forcing him to lay off up to half of his 21-member team.

Science magazine reported that the NIH raised the minimum postdoc salary to $61,008 in 2024 -- an 8% increase that fell far short of the $70,000 recommended by an NIH advisory group. Acting NIH director Lawrence Tabak acknowledged 'the current system is no longer sustainable,' but called improved pay 'a zero-sum game' within flat budgets. Faculty expressed concern that higher postdoc salaries would force smaller labs, with some warning they would simply hire fewer postdocs. Meanwhile, 87% of survey respondents expressed concerns about postdoc salaries, and postdocs routinely work 50-60 hour weeks (some reporting up to 80 hours), resulting in effective hourly wages that can fall below minimum wage. MIT and Princeton allocated temporary supplementary funding to cover the raises, while many other institutions provided no additional support -- illustrating the structural impossibility of paying researchers fairly within a grant-funded system where budgets have been flat for over a decade.

The NIH awarded transition grants to 172 fewer postdoctoral researchers in the first nine months of 2025 compared to the previous year -- a 10% reduction. Overall, 896 fewer new early-career grants were funded for undergraduates, PhD students, and postdocs, the lowest number since 2016. NIH cut approximately 2,100 grants worth around $9.5 billion, and indirect cost rates were slashed to 15% per grant, devastating university laboratory infrastructure. A breast cancer researcher at Harvard lost seven of her 18 lab employees after funding was frozen, while approximately 10,000 HHS termination notices were issued in March 2025, including 1,000 at the NIH -- 20% of which were later identified as errors.

Nature's landmark survey of 1,576 researchers found that more than 70% have tried and failed to reproduce another scientist's experiments, and more than half have failed to reproduce their own. Failure rates vary by discipline: 87% of chemists, 77% of biologists, 69% of physicists and engineers, and 67% of medical researchers reported inability to replicate published results. A follow-up 2024 survey of 1,630 biomedical researchers by Fierce Biotech found that 72% agreed their field faces a reproducibility crisis, with 62% blaming publish-or-perish culture and only 16% saying their institution had procedures to improve reproducibility. The crisis undermines the foundational integrity of the scientific record and wastes billions in research funding pursuing unreliable findings.

More than 14,000 retraction notices were issued in 2023, setting a record, with the annual number rising from approximately 1,000 to over 10,000 between 2015 and 2025 -- a 900% increase in less than a decade. Conservative estimates suggest up to 400,000 fraudulent articles have infiltrated scientific literature over 20 years. The phenomenon of "paper mills" -- commercial operations mass-producing fake studies -- has transformed the nature of misconduct, with output estimated to double every 1.5 years. Two-thirds of retractions involve misconduct, and the countries with the highest retraction counts between 2015-2025 are China (22,574; 45.8%), India (3,309), and the United States (2,655).

In a steady state, only 12.8% of PhD graduates can attain permanent academic positions in the US. In engineering, a professor graduates an average of 7.8 new PhDs during their career, but only one can replace that professor's position. Between 2005 and 2009, 100,000 doctorates were awarded against only 16,000 open professorships. Less than 17% of new science, engineering, and health PhDs find tenure-track positions within three years of graduation. With university expansion halted, the system is structurally saturated far beyond capacity to absorb new PhDs, creating a permanent underclass of highly trained researchers trapped in temporary positions with no path to stability.

A survey of over 700 international postdoctoral researchers at Harvard Medical School revealed that more than 40% spent over a month in their home countries waiting to renew US visas, with 5% spending more than six months -- effectively unable to work. Scholars from Asia experienced longer delays and higher costs than Europeans. In September 2025, the H-1B visa fee was raised to $100,000, while new requirements included mandatory disclosure of social media accounts and prolonged vetting. A Nature analysis found US-based scientists submitted 32% more applications to positions abroad in early 2025 compared to 2024, while applications to US jobs from European and Chinese scientists plummeted, signaling a brain drain from the world's largest research enterprise.